// App-Quantinova.ai

: “Problem Joint” a more patient relevant definition for joint morbidity in haemophilia

Researchers

Presenter

  • J. O'Hara

Principal Investigators

  • K. Khair

  • P. McLaughlin

  • B. O'Mahony

  • M. Laffan

  • J. Pasi

  • P. Chowdary

  • R. Curtis

  • M. Skinner

  • D. Noone

  • J. Willan

  • T. Burke

Medical Centers

  • Faculty of Health and Social Care, University of Chester, Chester

  • HCD Economics, Daresbury

  • Great Ormond Street Hospital

  • Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, United Kingdom

  • European Haemophilia Consortium, Burssels, Belgium

  • Haematology, Imperial College London

  • Haematology, Barts Health NHS Trust

  • Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free NHS Trust, London, United Kingdom

  • University of Southern California, Los Angeles, CA

  • Institute for Policy Advancement Ltd., Washington, USA

  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Locations

  • United Kingdom

  • Belgium

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved